Neville Rodie & Shaw’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.86M Sell
60,443
-240
-0.4% -$34.9K 0.57% 44
2026
Q1
$8.77M Sell
60,683
-1,660
-3% -$252K 0.64% 42
2025
Q4
$8.93M Sell
62,343
-1,814
-3% -$267K 0.63% 39
2025
Q3
$9.86M Sell
64,157
-6,001
-9% -$937K 0.71% 39
2025
Q2
$11.2M Sell
70,158
-2,426
-3% -$396K 0.83% 34
2025
Q1
$12.4M Sell
72,584
-3,050
-4% -$511K 0.97% 31
2024
Q4
$12.7M Sell
75,634
-1,870
-2% -$318K 0.92% 31
2024
Q3
$13.4M Sell
77,504
-2,620
-3% -$445K 0.99% 29
2024
Q2
$13.2M Sell
80,124
-578
-0.7% -$94.5K 1% 29
2024
Q1
$13.1M Sell
80,702
-2,044
-2% -$321K 1% 29
2023
Q4
$12.1M Sell
82,746
-1,273
-2% -$189K 0.99% 27
2023
Q3
$12.3M Sell
84,019
-945
-1% -$144K 1.09% 26
2023
Q2
$12.9M Buy
84,964
+705
+0.8% +$106K 1.11% 25
2023
Q1
$12.5M Sell
84,259
-959
-1% -$137K 1.14% 26
2022
Q4
$12.9M Buy
85,218
+2,094
+3% +$294K 1.21% 25
2022
Q3
$10.5M Sell
83,124
-2,670
-3% -$379K 1.03% 29
2022
Q2
$12.3M Sell
85,794
-530
-0.6% -$79.7K 1.1% 28
2022
Q1
$13.4M Sell
86,324
-300
-0.3% -$46.9K 1% 33
2021
Q4
$14.2M Sell
86,624
-957
-1% -$142K 1% 34
2021
Q3
$12.2M Sell
87,581
-283
-0.3% -$40.1K 0.95% 35
2021
Q2
$11.9M Sell
87,864
-1,968
-2% -$266K 0.91% 34
2021
Q1
$12.2M Sell
89,832
-785
-0.9% -$102K 1.01% 33
2020
Q4
$12.6M Sell
90,617
-6,786
-7% -$948K 1.09% 30
2020
Q3
$13.5M Sell
97,403
-1,067
-1% -$142K 1.28% 23
2020
Q2
$11.8M Sell
98,470
-1,600
-2% -$187K 1.22% 26
2020
Q1
$11M Sell
100,070
-791
-0.8% -$94.9K 1.34% 19
2019
Q4
$12.6M Buy
100,861
+452
+0.5% +$55.3K 1.24% 21
2019
Q3
$12.5M Buy
100,409
+2,825
+3% +$334K 1.32% 21
2019
Q2
$10.7M Sell
97,584
-510
-0.5% -$54.4K 1.13% 24
2019
Q1
$10.2M Sell
98,094
-1,790
-2% -$174K 1.08% 26
2018
Q4
$9.18M Sell
99,884
-625
-0.6% -$55.9K 1.11% 27
2018
Q3
$8.37M Sell
100,509
-7,720
-7% -$631K 0.83% 41
2018
Q2
$8.45M Buy
108,229
+5,686
+6% +$428K 0.89% 39
2018
Q1
$8.13M Sell
102,543
-1,730
-2% -$144K 0.9% 36
2017
Q4
$9.58M Sell
104,273
-570
-0.5% -$51.3K 1.01% 31
2017
Q3
$9.54M Sell
104,843
-5,290
-5% -$482K 1.06% 31
2017
Q2
$9.6M Sell
110,133
-3,050
-3% -$269K 1.1% 29
2017
Q1
$10.2M Sell
113,183
-3,376
-3% -$299K 1.16% 25
2016
Q4
$9.8M Sell
116,559
-2,744
-2% -$234K 1.16% 26
2016
Q3
$10.7M Sell
119,303
-960
-0.8% -$83.4K 1.26% 21
2016
Q2
$10.2M Sell
120,263
-2,300
-2% -$189K 1.22% 21
2016
Q1
$10.1M Sell
122,563
-1,400
-1% -$113K 1.23% 22
2015
Q4
$9.84M Sell
123,963
-4,471
-3% -$342K 1.18% 22
2015
Q3
$9.24M Buy
128,434
+11,040
+9% +$828K 1.13% 23
2015
Q2
$9.19M Sell
117,394
-5,713
-5% -$460K 1.01% 26
2015
Q1
$10.1M Sell
123,107
-6,095
-5% -$524K 1.05% 24
2014
Q4
$11.8M Buy
129,202
+215
+0.2% +$18.9K 1.19% 23
2014
Q3
$10.8M Buy
128,987
+4,190
+3% +$343K 1.06% 25
2014
Q2
$9.81M Sell
124,797
-355
-0.3% -$28.6K 0.98% 29
2014
Q1
$10.1M Sell
125,152
-6,126
-5% -$483K 1.09% 27
2013
Q4
$10.7M Sell
131,278
-5,452
-4% -$444K 1.16% 26
2013
Q3
$10.3M Sell
136,730
-3,600
-3% -$286K 1.2% 23
2013
Q2
$10.8M Buy
+140,330
New +$11M 1.31% 22

Other funds holding PG

Neville Rodie & Shaw's PG Position: Q2 2026 in Review

Neville Rodie & Shaw reduced its Procter & Gamble (PG) stake by 0.4% in Q2 2026, selling an estimated $34.9K and leaving 60,443 shares worth $8.86M. The position accounts for 0.57% of the portfolio, ranked #44.

Neville Rodie & Shaw first reported a position in PG in Q2 2013 and has held it in 53 quarters since. The position peaked at $14.2M in Q4 2021. 1,357 funds tracked by Wall St. Rank hold PG as of Q2 2026.

  • Neville Rodie & Shaw held 60,443 shares of Procter & Gamble worth $8.86M as of Q2 2026.
  • Neville Rodie & Shaw sold 240 Procter & Gamble shares in Q2 2026, an estimated $34.9K.
  • Procter & Gamble made up 0.57% of Neville Rodie & Shaw's portfolio in Q2 2026, its #44 holding.
  • Neville Rodie & Shaw first reported a position in Procter & Gamble in Q2 2013 and has held it in 53 quarters since.
  • Neville Rodie & Shaw's Procter & Gamble position peaked at $14.2M in Q4 2021.
  • 1,357 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2026.

Based on Neville Rodie & Shaw's 13F filing for Q2 2026, filed 6 Jul 2026.